Interpretation of design ideas and implementation process of randomized controlled trial of Xuebijing injection in the treatment of severe community-acquired pneumonia
10.3760/cma.j.issn.2095-4352.2019.07.003
- VernacularTitle:血必净注射液治疗重症社区获得性肺炎疗效的随机对照临床试验设计思路与实施过程解读
- Author:
Chunxue BAI
1
;
Yao CHEN
;
Hongcai SHANG
;
Xuezhong YU
;
Kaijiang YU
;
Yongming YAO
Author Information
1. 复旦大学附属中山医院呼吸科
- Keywords:
Xuebijing injection;
Severe community-acquired pneumonia;
Randomized controlled trial
- From:
Chinese Critical Care Medicine
2019;31(7):811-814
- CountryChina
- Language:Chinese
-
Abstract:
A multicenter blinded randomized controlled trial (RCT) was conducted in accordance with international clinical trial standards to evaluate the efficacy and safety of Xuebijing injection in the treatment of severe community-acquired pneumonia (SCAP) under strict quality control condition. This article aims to illustrate key contents of the design ideas and implementation process of the RCT of Xuebijing injection in the treatment of SCAP, including the selection of research objects, design, implementation, and insights, etc., share experience with researchers of the respiratory and critical care, and provide reference for future studies in critical care.
